Form 144/A - Report of proposed sale of securities: [Amend]
SEC Accession No. 0001628280-25-050285
Filing Date
2025-11-06
Accepted
2025-11-06 16:54:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144/A  
1 primary_doc.xml 144/A 3978
  Complete submission text file 0001628280-25-050285.txt   5579
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Subject) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144/A | Act: 33 | File No.: 001-39186 | Film No.: 251459315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address
Edwards Larry Todd (Reporting) CIK: 0001994805 (see all company filings)

Type: 144/A